|
The webcasts contain video and slides of presenters at ECOP 2014. Visible in all browsers, incl. iPad. |
ECOP 2 Congress |
Organised by  |
Produced by |
.JPG) |
Klaus Meier Germany and Mikael Daouphars, France |
.JPG) |
.JPG) |
Keynote: Quo Vadis Regenerative Medicne? M. Ratajczak (USA) |
||
Pricing and Shortages of anticancer drugs |
||||||
.JPG) |
Cost explosion of anticancer drugs A. Palozzo, Italy |
.JPG) |
Overview of ESMO Survey of Availability of Antineoplastic Drugs M. Saar, Estonia |
|||
.JPG) |
Shortages of essential Cytotoxic Drugs in Europe: Call for Action G. Wiedemann (Germany) |
.JPG) |
Roundtable: Drug Shortages A. Vulto, Netherlands F. Houyez, France AL De Lima Marcal, United Kingdom |
.JPG) |
.JPG) |
|
New Horizons - Cancer Treatment, Great views from the Top Papers |
||||||
.JPG) |
Dual Her2 blockade for Breast Cancer A. Munilla Das, Spain |
.JPG) |
L. Hardy, United Kingdom |
|||
Does One Size Fit All? the importance of pharmacogenetics |
||||||
.JPG) |
Where we are and where we go: Oncology Pharmacy Challenge M Garcia Gil, Spain |
.JPG) |
Pharmacogenomics and Colorectal Carcinoma I Kirac, Croatia |
|||
Is my mother Safe in Hospital Cancer Care? |
||||||
.JPG) |
Computerized Order Process, Influence on Prescription Errors T. Schoening, Germany |
.JPG) |
Medical errors in Clinical Practice I Netikova, Czech Republic |
|||
 |
Pharmacovigilance: Monitoring of Adverse Drug Reactions M Sonc, Slovenia |
.JPG) |
Patient Safety in a paperless Hospital MJ Tames, Spain |
|||
Debate: This house believes in biosimilars |
Debate: This house does not substitute with biosimilars |
|||||
.JPG) |
|
.JPG) |
.JPG) |
|||